| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/15/2008 | WO2008008310A3 Tyrosine kinase inhibitors |
| 05/15/2008 | WO2007130825A3 Fused heterocyclic compounds and their use as mglur5 modulators |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114009 Farnesyl Transferase Inhibiting 1,2-Annelated Quinoline Enantiomer |
| 05/15/2008 | US20080114005 2-Methyl-2-{4-[2-(2-methyl-4-oxo-4H-quinazolin-3-yl)-ethylamino]-phenylsulfanyl}-propionic acid ethyl ester; peroxisome proliferaor activated receptors alfa and gamma agonist; diabetic dyslipidemia, metabolic syndrome, diabetes, non-insulin dependent diabetes, cardiovascular disease, and obesity |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113991 Pyridopyrazines and the use thereof as kinase inhibitors |
| 05/15/2008 | US20080113978 Substituted imidazo[1,2-b]pyridazine compounds such as N-{4-chloro-5-[8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazin-3-yl]-thiazol-2-yl}-morpholine; use as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases |
| 05/15/2008 | US20080113977 For example, 7-Bromo-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline; for treating physiological disorders, particularly congestive heart disease |
| 05/15/2008 | US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 05/15/2008 | US20080113971 improved potency; reduced undesirable side effects; pain, inflammation, arthritis etc; ethyl 1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazole-5-carboxylate dihydrochloride |
| 05/15/2008 | US20080113966 CGRP (Calcitonin Gene-Related Peptide); migraine and cluster headache; compounds based on 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine or 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine |
| 05/15/2008 | US20080113963 Prepared by submitting benzimidazole compound to a cyclization reaction; gastric secretion inhibiting and gastric and intestinal protective action properties; for gastrointestinal disorders; for example, 2,3-Dimethyl-8-phenyl-3,6,7,8-tetrahydro-chromeno[7,8-a]imidazole-5-carboxylic acid dimethylamide |
| 05/15/2008 | US20080113956 Substituted Porphyrins |
| 05/15/2008 | US20080110369 Phthalocyanine Compounds And Their Use In Ink-Jet Printing |
| 05/15/2008 | CA2669465A1 Imidazopyrazines as protein kinase inhibitors |
| 05/15/2008 | CA2669432A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 05/15/2008 | CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | CA2668682A1 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 05/15/2008 | CA2667936A1 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 05/15/2008 | CA2667487A1 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 05/15/2008 | CA2667345A1 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 05/15/2008 | CA2663925A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 05/14/2008 | EP1921080A1 Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives |
| 05/14/2008 | EP1921079A1 Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
| 05/14/2008 | EP1919922A1 Method for synthesizing spiro quaternary ammonium systems |
| 05/14/2008 | EP1919921A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 05/14/2008 | EP1919920A2 Pentacyclic kinase inhibitors |
| 05/14/2008 | EP1919919A1 Pyridazinone derivatives used for the treatment of pain |
| 05/14/2008 | EP1919918A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919917A2 Preparation of a 7h-pyrrolo[2,3-d]pyrimidine derivative |
| 05/14/2008 | EP1919916A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 05/14/2008 | EP1919915A2 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 05/14/2008 | EP1919914A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919913A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919912A1 Process for enantiomeric separation of zopiclone |
| 05/14/2008 | EP1919911A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 05/14/2008 | EP1919854A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/14/2008 | EP1919482A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 05/14/2008 | EP1919470A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS |
| 05/14/2008 | EP1919287A2 Organic compounds for treating reduced dopamine receptor signalling activity |
| 05/14/2008 | EP1689736A4 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | CN101180299A Acetylenyl-pyrazolo-pvrimidine derivatives as MGLUR2 antagonists |
| 05/14/2008 | CN101180297A Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 05/14/2008 | CN101177429A Topoisomerase enzyme inhibitor, preparation method and use thereof |
| 05/14/2008 | CN101177428A One-step method for synthesizing tryptamine ketone and derivative |
| 05/14/2008 | CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 05/14/2008 | CN101177370A Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid |
| 05/14/2008 | CN100387599C Process for making carbapenem compounds |
| 05/14/2008 | CN100387581C Process to produce oxazolidinones |
| 05/14/2008 | CN100387580C Tricyclic triazolobenzazepine, derivatives, process for producing the same, and antiallergic |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371861 Process for preparing ring-fluorinated aromatics |
| 05/13/2008 | US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O |
| 05/13/2008 | US7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371524 Substituted azaporphyrins as fluorescence labels |
| 05/13/2008 | CA2327395C New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | CA2324953C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/13/2008 | CA2196995C Spiro-azabicyclic compounds useful in therapy |
| 05/08/2008 | WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053301A2 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/08/2008 | WO2008052964A1 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/08/2008 | WO2008052814A1 Macrocyclic nitrogen compounds and use thereof |
| 05/08/2008 | WO2008052734A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | WO2008052733A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | WO2008052628A1 Triazabenzo[e]azulene derivatives for the treatment of tumors |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2008016192A3 Fused heterocyclic derivative and use thereof |
| 05/08/2008 | WO2008012635A3 Amine derivatives useful as anticancer agents |
| 05/08/2008 | US20080108831 Used in electrooptical systems such as TV screens, liquid crystal displays, charge coupled devices, plasma displays or electroluminescent displays; do not tend to aggregate, show very good dispersibility; high transparence and pure hue |
| 05/08/2008 | US20080108806 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent |
| 05/08/2008 | US20080108644 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease |
| 05/08/2008 | US20080108634 Novel phenylalanine derivatives |
| 05/08/2008 | US20080108632 Hcv protease inhibitors |
| 05/08/2008 | US20080108616 as serine/threonine, fusion, and tyrosine kinase receptors as nerve and fibroblast growth factor; abnormal activation of immune and nervous systems; antiproliferative; lung; 4-(3-Trifluoromethyl-phenylamino)-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-morpholin-4-yl-phenylcarbamoyl)-phenyl]-amide |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108604 sugar transport enhancement agent; antidiabetic and hypoglycemic agent; obesity, diabetic nephropathy, retinopathy, macrovascular disease, glucose tolerance anomaly; cyclization of 4-(2-aminocyclohexylamino)-3-pyrroline-2-one by aldehyde followed by acylation |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108593 metal phthalocyanine ; antiallergen; enzyme-like catalyst reaction of metal phthalocyanine; allergen is denatured by ability of adsorbing of the metal phthalocyanine and reacting as a catalyst on an oxidation-reduction reaction |
| 05/08/2008 | DE102006051796A1 Triaza-benzo[e]azulenderivate Triaza-benzo [e] azulene derivatives |
| 05/08/2008 | DE102006049452A1 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln Tetrahydropyrolopiperazin substituted compounds and their use in medicaments |
| 05/08/2008 | CA2822776A1 Inhibitors of histone deacetylase |
| 05/08/2008 | CA2668562A1 Triazabenzo(e)azulene derivatives for the treatment of tumours |
| 05/08/2008 | CA2668286A1 Bruton's tyrosine kinase activity probe and method of using |
| 05/08/2008 | CA2668255A1 Anilinopiperazine derivatives and methods of use thereof |
| 05/08/2008 | CA2667963A1 3-aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/08/2008 | CA2667962A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | CA2667960A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 05/08/2008 | CA2667920A1 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 05/08/2008 | CA2667839A1 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/07/2008 | EP1918292A1 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/07/2008 | EP1918291A1 3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/07/2008 | EP1918290A1 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |